NCT00980642

Brief Summary

Our primary hypothesis is that the Draeger dual-sensor temperature monitoring system, used at the forehead, is sufficiently accurate compared to tympanic, bladder or esophageal temperature and oral temperature for routine clinical use during hypothermic conditions, as well as during fever.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2010

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 21, 2009

Completed
5 months until next milestone

Study Start

First participant enrolled

March 1, 2010

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2012

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2012

Completed
4.9 years until next milestone

Results Posted

Study results publicly available

June 14, 2017

Completed
Last Updated

June 14, 2017

Status Verified

May 1, 2017

Enrollment Period

1.9 years

First QC Date

September 18, 2009

Results QC Date

April 6, 2017

Last Update Submit

May 15, 2017

Conditions

Keywords

surgerythermometernon-invasiveinteroperative core temperatureanesthesia

Outcome Measures

Primary Outcomes (1)

  • The Bias Between Temperature Measured by Drager Double-sensor vs Core Temperature

    Determine if the Drager double-sensor temperature monitoring system, used at the forehead is accurate compared to esophageal temperature for general anesthesia group and bladder temperature for regional anesthesia group.

    From anesthesia induction to the end of surgery

Secondary Outcomes (2)

  • Sensitivity for Detection of Hypothermia

    From anesthesia induction to the end of surgery

  • Specificity for Detection of Hypothermia

    From anesthesia induction to the end of surgery

Study Arms (2)

General anesthesia

OTHER

Temperature is measured by Draeger double-sensor and esophageal stethoscope temperature sensor every 5-min during the surgery.

Device: Draeger double-sensorDevice: Esophageal stethoscope temperature sensor

Regional anesthesia

OTHER

Temperature is measured by Draeger double-sensor and Foley catheter temperature sensor every 5-min during the surgery.

Device: Draeger double-sensorDevice: Foley catheter temperature sensor

Interventions

The sensor will be attached to the patient's forehead with adhesive tape, and a small amount of contact gel will be applied between sensor and skin.

General anesthesiaRegional anesthesia

Esophageal temperature is measured by sensors incorporated into an esophageal stethoscope during the surgery.

General anesthesia

Urinary bladder temperature is measured via a sensor incorporated into a Foley catheter during the surgery

Regional anesthesia

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing trauma surgery with general anesthesia
  • Patients undergoing orthopedic surgery with regional anesthesia

You may not qualify if:

  • Younger than 18 or older than 80 years of age
  • Have a pre-existing nasogastric tube
  • Require bispectral index monitoring
  • Upper esophageal disease
  • Forehead rash or infection
  • Oral infection or trauma
  • Ear infection or drainage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic

Cleveland, Ohio, 44195, United States

Location

MeSH Terms

Conditions

Hypothermia

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Andrea Kurz
Organization
Cleveland Clinic

Study Officials

  • Andrea Kurz, M.D.

    The Cleveland Clinic

    PRINCIPAL INVESTIGATOR
  • Daniel I Sessler, M.D.

    The Cleveland Clinic

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 18, 2009

First Posted

September 21, 2009

Study Start

March 1, 2010

Primary Completion

February 1, 2012

Study Completion

August 1, 2012

Last Updated

June 14, 2017

Results First Posted

June 14, 2017

Record last verified: 2017-05

Locations